Sungjin Chung (The Catholic University of Korea College of Medicine)

1999, MD, Hanyang University, Seoul, Korea

2003, MMSc, The Graduate School of Hanyang University, Seoul, Korea

2008, PhD, The Graduate School of Hanyang University, Seoul, Korea

2017-2018, Visiting Scholar, Department of Medicine, Vanderbilt University School of Medicine, TN, USA

2010-current, Professor, Department of Internal Medicine, The Catholic University of Korea College of Medicine, Seoul, Korea

Hypertension; Renal physiology

Chung S, Son HE, Lee JP, Park HC; Korean Society of Nephrology. The Proposed Chronic Kidney Disease Management Act in Korea: A Step Toward a National Strategy for Kidney Disease Prevention and Care. Electrolyte Blood Press 2026;24:1-5.

Jung J, Juarez S, Koh ES, Chung S. Advances in Hyperkalemia Management and the Emerging Role of Sodium Zirconium Cyclosilicate. Electrolyte Blood Press 2026;24:73-80.

Lee SY, Han K, Kwon HS, Koh ES, Chung S. Fecal Calprotectin as a Prognostic Biomarker for Mortality and Renal Outcomes in Chronic Kidney Disease. Biomolecules 2025;15:557.

Koh ES, Chung S. Recent Update on Acute Kidney Injury-to-Chronic Kidney Disease Transition. Yonsei Med J 2024;65:247-256.

Arici M, Assaad-Khalil SH, Bertoluci MC, Choo J, Lee YJ, Madero M, Rosa Diez GJ, Sánchez Polo V, Chung S, Thanachayanont T, Pollock C. Results from a cross-specialty consensus on optimal management of patients with chronic kidney disease (CKD): from screening to complications. BMJ Open 2024;14:e080891.